Approval · Notice of Compliance 14047 · 2013
ACID REDUCER: Notice of Compliance 14047
Issued January 25, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14047
- Date
- January 25, 2013
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Therapeutic class
- Histamine h2-receptor antagonist
- Canadian reference product
- ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION (Mcneil Consumer Healthcare)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID REDUCER | 02400103 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB